Stock 002437 HARBIN GLORIA PHARMACEUTICALS CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Harbin Gloria Pharmaceuticals Co., Ltd

Equities

002437

CNE100000QG8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.05 CNY +1.49% Intraday chart for Harbin Gloria Pharmaceuticals Co., Ltd +3.02% -18.33%
Apr. 12 HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 HARBIN GLORIA PHARMACEUTICALS Co., LTD completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. CI

Business Summary

HARBIN GLORIA PHARMACEUTICALS Co., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's products include cardiovascular and cerebrovascular drugs, orthopedic drugs, nutritional drugs, anti-infective drugs, immune-enhancing drugs, diabetes drugs, antineoplastic drugs and electrolytes drugs. The Company is also engaged in the agency, research and development of pharmaceuticals, the provision of clinical services and financial investment business. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Medicine
95.9 %
2,967 95.5 % 2,517 95.9 % -15.15%
Traditional Chinese Medicine
3.8 %
135 4.3 % 101 3.8 % -24.96%
Other Business
0.3 %
5 0.2 % 7 0.3 % +37.80%
Others
0.0 %
2 0.1 % 1 0.0 % -52.00%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.9 %
3,102 99.8 % 2,624 99.9 % -15.42%
Abroad
0.1 %
6 0.2 % 2 0.1 % -61.30%

Managers

Managers TitleAgeSince
Lei Feng Guo CEO
 Chief Executive Officer 51 22-11-10
Zuo Zhe Ji DFI
 Director of Finance/CFO 47 20-12-17
Jia Feng Zang CTO
 Chief Tech/Sci/R&D Officer 48 21-04-26
Kang Zhou BRD
 Director/Board Member 40 18-04-17
Xiu Qiang Diao BRD
 Director/Board Member 47 12-10-31
Xue Long Bai IRC
 Investor Relations Contact - -
Ran Wang LAW
 General Counsel 39 22-12-25
Yue Yin Liu SEC
 Corporate Secretary 38 -

Members of the board

Members of the board TitleAgeSince
Jin Hu CHM
 Chairman 48 20-07-21
Min Pan BRD
 Director/Board Member 53 22-12-19
Xiao Dan Zhang BRD
 Director/Board Member 49 22-12-19
Lei Feng Guo CEO
 Chief Executive Officer 51 22-11-10
Yue Yin Liu SEC
 Corporate Secretary 38 -
Li Na Wang BRD
 Director/Board Member 46 -
Kang Zhou BRD
 Director/Board Member 40 18-04-17
Zuo Zhe Ji DFI
 Director of Finance/CFO 47 20-12-17
Yu Bing Song CHM
 Chairman 48 23-07-27
Feng Jiang BRD
 Director/Board Member 42 23-07-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,270,513,950 2,036,825,317 ( 89.71 %) 0 89.71 %

Shareholders

NameEquities%Valuation
Eastern Spring Capital Management Co., Ltd.
6.816 %
149,326,597 6.816 % 44 M ¥
Zhen Yu Shen
5.043 %
110,490,000 5.043 % 33 M ¥
Zhu Ji Man Family
4.550 %
99,682,722 4.550 % 30 M ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
4.236 %
92,800,000 4.236 % 27 M ¥
Jue Sun
3.697 %
81,000,000 3.697 % 24 M ¥
Jianghai Securities Co. Ltd. (Investment Management)
3.230 %
70,760,872 3.230 % 21 M ¥
Meng Nan Liu
3.122 %
68,396,914 3.122 % 20 M ¥
Bo Lin Chen
2.031 %
44,500,000 2.031 % 13 M ¥
Shanghai Fangyuanda Venture Capital LP
1.606 %
35,190,000 1.606 % 10 M ¥
Shi Qing Tao
1.187 %
26,000,000 1.187 % 8 M ¥

Company contact information

Harbin Gloria Pharmaceuticals Co., Ltd.

Building 28, Ronghui Garden Yuhua Road, Area B

101318, Beijing

+86 451 5735 1368

http://www.gloria.cc
address Harbin Gloria Pharmaceuticals Co., Ltd(002437)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
HARBIN GLORIA PHARMACEUTICALS CO., LTD Stock Harbin Gloria Pharmaceuticals Co., Ltd
-18.33% 642M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.89B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.82% 14.45B
CIPLA LIMITED Stock Cipla Limited
+12.99% 13.63B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.45% 11.49B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.85B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.35% 5.06B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002437 Stock
  4. Company Harbin Gloria Pharmaceuticals Co., Ltd